![](/img/cover-not-exists.png)
P-0042 * PHARMACOKINETICS OF ERLOTINIB AND ITS MAIN METABOLITE OSI420 IN ADVANCED PANCREATIC CANCER PATIENTS WHEN COMBINED WITH ESCALATING DOSES OF CAPECITABINE
Sahmanovic, A., Buchner, P., Lichtneckert, M., Dittrich, C., Czejka, M.Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt203.40
Date:
June, 2013
File:
PDF, 262 KB
english, 2013